Kevin Rocco, CEO

Biorez is a regenerative medicine company developing bioresorbable scaffolds for musculoskeletal procedures. Our implants are designed to restore joint stability, regenerate functional tissue, and return patients to pre-injury activity levels. The company has demonstrated proof of concept of its tissue engineered technology platform in a clinical safety study for ACL reconstruction. Building on this momentum, Biorez is developing a pipeline of products for commercial release in early 2020.